Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.

Zoine JT, Knight KA, Fleischer LC, Sutton KS, Goldsmith KC, Doering CB, Spencer HT.

Oncoimmunology. 2019 May 27;8(8):1593804. doi: 10.1080/2162402X.2019.1593804. eCollection 2019.

2.

Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.

Esbenshade AJ, Kahalley LS, Baertschiger R, Dasgupta R, Goldsmith KC, Nathan PC, Harker-Murray P, Kitko CL, Kolb EA, Murphy ES, Muscal JA, Pierson CR, Reed D, Schore R, Unguru Y, Venkatramani R, Wistinghausen B, Dhall G.

Pediatr Blood Cancer. 2019 Jul 16:e27920. doi: 10.1002/pbc.27920. [Epub ahead of print]

PMID:
31309744
3.

Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions.

Amiel SA, Choudhary P, Jacob P, Smith EL, De Zoysa N, Gonder-Frederick L, Kendall M, Heller S, Brooks A, Toschi E, Kariyawasam D, Potts L, Healy A, Rogers H, Sevdalis N, Stadler M, Qayyum M, Bakolis I, Goldsmith K.

BMJ Open. 2019 Jun 16;9(6):e030356. doi: 10.1136/bmjopen-2019-030356.

4.

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma.

Maximov V, Chen Z, Wei Y, Robinson MH, Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ, Northcott PA, Hambardzumyan D, Kenney AM.

Nat Commun. 2019 Jun 3;10(1):2410. doi: 10.1038/s41467-019-10458-9.

5.

A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders.

Rayner C, Coleman JRI, Purves KL, Hodsoll J, Goldsmith K, Alpers GW, Andersson E, Arolt V, Boberg J, Bögels S, Creswell C, Cooper P, Curtis C, Deckert J, Domschke K, El Alaoui S, Fehm L, Fydrich T, Gerlach AL, Grocholewski A, Hahlweg K, Hamm A, Hedman E, Heiervang ER, Hudson JL, Jöhren P, Keers R, Kircher T, Lang T, Lavebratt C, Lee SH, Lester KJ, Lindefors N, Margraf J, Nauta M, Pané-Farré CA, Pauli P, Rapee RM, Reif A, Rief W, Roberts S, Schalling M, Schneider S, Silverman WK, Ströhle A, Teismann T, Thastum M, Wannemüller A, Weber H, Wittchen HU, Wolf C, Rück C, Breen G, Eley TC.

Transl Psychiatry. 2019 May 23;9(1):150. doi: 10.1038/s41398-019-0481-y.

6.

Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.

Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, McCrone P, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.

Health Technol Assess. 2019 Apr;23(17):1-154. doi: 10.3310/hta23170.

7.

Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome.

Windgassen S, Moss-Morris R, Everitt H, Sibelli A, Goldsmith K, Chalder T.

Behav Ther. 2019 May;50(3):594-607. doi: 10.1016/j.beth.2018.09.006. Epub 2018 Sep 21.

PMID:
31030876
8.

Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.

Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop F, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R; ACTIB trial group.

Gut. 2019 Sep;68(9):1613-1623. doi: 10.1136/gutjnl-2018-317805. Epub 2019 Apr 10.

9.

Childhood gender-typed behavior and emotional or peer problems: a prospective birth-cohort study.

Warren AS, Goldsmith KA, Rimes KA.

J Child Psychol Psychiatry. 2019 Aug;60(8):888-896. doi: 10.1111/jcpp.13051. Epub 2019 Mar 25.

PMID:
30907437
10.

The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al.

Sharpe M, Goldsmith K, Chalder T.

BMC Psychol. 2019 Mar 12;7(1):15. doi: 10.1186/s40359-019-0288-x.

11.
12.

Adjustment with aphasia after stroke: study protocol for a pilot feasibility randomised controlled trial for SUpporting wellbeing through PEeR Befriending (SUPERB).

Hilari K, Behn N, Marshall J, Simpson A, Thomas S, Northcott S, Flood C, McVicker S, Jofre-Bonet M, Moss B, James K, Goldsmith K.

Pilot Feasibility Stud. 2019 Jan 22;5:14. doi: 10.1186/s40814-019-0397-6. eCollection 2019.

13.

Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety.

Windgassen S, Moss-Morris R, Goldsmith K, Chalder T.

J Psychosom Res. 2019 Mar;118:73-82. doi: 10.1016/j.jpsychores.2018.11.013. Epub 2018 Nov 22.

PMID:
30522750
14.

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

DuBois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith K, Granger MM, Weiss B, Park JR, Macy ME, Cohn SL, Yanik G, Wagner LM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Boucher N, Czarnecki S, Luo C, Tsao-Wei D, Matthay KK, Marachelian A.

Clin Cancer Res. 2018 Dec 15;24(24):6142-6149. doi: 10.1158/1078-0432.CCR-18-1381. Epub 2018 Aug 9.

PMID:
30093449
15.

Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.

Place AE, Goldsmith K, Bourquin JP, Loh ML, Gore L, Morgenstern DA, Sanzgiri Y, Hoffman D, Zhou Y, Ross JA, Prine B, Shebley M, McNamee M, Farazi T, Kim SY, Verdugo M, Lash-Fleming L, Zwaan CM, Vormoor J.

Future Oncol. 2018 Sep;14(21):2115-2129. doi: 10.2217/fon-2018-0121. Epub 2018 Mar 29.

16.

The importance of cluster analysis for enhancing clinical practice: an example from irritable bowel syndrome.

Windgassen S, Moss-Morris R, Goldsmith K, Chalder T.

J Ment Health. 2018 Apr;27(2):94-96. doi: 10.1080/09638237.2018.1437615. Epub 2018 Feb 15. No abstract available.

PMID:
29447026
17.

Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction.

Runco DV, Josephson CD, Raikar SS, Goldsmith KC, Lew G, Pauly M, Fasano RM.

Transfusion. 2018 May;58(5):1149-1156. doi: 10.1111/trf.14512. Epub 2018 Feb 4.

18.

Tutorial: The practical application of longitudinal structural equation mediation models in clinical trials.

Goldsmith KA, MacKinnon DP, Chalder T, White PD, Sharpe M, Pickles A.

Psychol Methods. 2018 Jun;23(2):191-207. doi: 10.1037/met0000154. Epub 2017 Dec 28.

19.

Erratum: Author Correction: Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile.

Kumar R, Yi N, Zhi D, Eipers P, Goldsmith KT, Dixon P, Crossman DK, Crowley MR, Lefkowitz EJ, Rodriguez JM, Morrow CD.

NPJ Biofilms Microbiomes. 2017 Nov 3;3:29. doi: 10.1038/s41522-017-0037-y. eCollection 2017.

20.

Psychometric Properties and Factor Structure of a Long and Shortened Version of the Cognitive and Behavioural Responses Questionnaire.

Ryan EG, Vitoratou S, Goldsmith KA, Chalder T.

Psychosom Med. 2018 Feb/Mar;80(2):230-237. doi: 10.1097/PSY.0000000000000536.

PMID:
29023262
21.

Response to the editorial by Dr Geraghty.

White PD, Chalder T, Sharpe M, Angus BJ, Baber HL, Bavinton J, Burgess M, Clark LV, Cox DL, DeCesare JC, Goldsmith KA, Johnson AL, McCrone P, Murphy G, Murphy M, O'Dowd H, Potts L, Walwyn R, Wilks D.

J Health Psychol. 2017 Aug;22(9):1113-1117. doi: 10.1177/1359105316688953. Epub 2017 Jan 24.

PMID:
28805524
22.

Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).

Marwood L, Taylor R, Goldsmith K, Romeo R, Holland R, Pickles A, Hutchinson J, Dietch D, Cipriani A, Nair R, Attenburrow MJ, Young AH, Geddes J, McAllister-Williams RH, Cleare AJ.

BMC Psychiatry. 2017 Jun 26;17(1):231. doi: 10.1186/s12888-017-1393-0.

23.

Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile.

Kumar R, Yi N, Zhi D, Eipers P, Goldsmith KT, Dixon P, Crossman DK, Crowley MR, Lefkowitz EJ, Rodriguez JM, Morrow CD.

NPJ Biofilms Microbiomes. 2017 Jun 7;3:12. doi: 10.1038/s41522-017-0020-7. eCollection 2017. Erratum in: NPJ Biofilms Microbiomes. 2017 Nov 3;3:29.

24.

The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.

Windgassen S, Moss-Morris R, Chilcot J, Sibelli A, Goldsmith K, Chalder T.

Br J Health Psychol. 2017 Nov;22(4):701-736. doi: 10.1111/bjhp.12250. Epub 2017 Jun 1. Review.

PMID:
28573818
25.

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.

Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK, Groshen S, Asgharzadeh S, Sposto R, Seeger RC.

Clin Cancer Res. 2017 Sep 15;23(18):5374-5383. doi: 10.1158/1078-0432.CCR-16-2647. Epub 2017 May 30.

26.

Guided Self-Help for Patients with Chronic Fatigue Syndrome Prior to Starting Cognitive Behavioural Therapy: a Cohort Study.

Ali S, Goldsmith K, Burgess M, Chalder T.

Behav Cogn Psychother. 2017 Sep;45(5):448-466. doi: 10.1017/S135246581700025X. Epub 2017 May 5.

PMID:
28473005
27.

Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement.

Ferris MJ, Danish H, Switchenko JM, Deng C, George BA, Goldsmith KC, Wasilewski KJ, Cash WT, Khan MK, Eaton BR, Esiashvili N.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):806-812. doi: 10.1016/j.ijrobp.2016.11.043. Epub 2016 Nov 27.

28.

Concurrent myeloid sarcoma, atypical teratoid/rhabdoid tumor, and hypereosinophilia in an infant with a germline SMARCB1 mutation.

Metts JL, Park SI, Soares BP, Fong C, Biegel JA, Goldsmith KC.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26460. Epub 2017 Jan 23.

PMID:
28111898
29.

The NOURISHED randomised controlled trial comparing mentalisation-based treatment for eating disorders (MBT-ED) with specialist supportive clinical management (SSCM-ED) for patients with eating disorders and symptoms of borderline personality disorder.

Robinson P, Hellier J, Barrett B, Barzdaitiene D, Bateman A, Bogaardt A, Clare A, Somers N, O'Callaghan A, Goldsmith K, Kern N, Schmidt U, Morando S, Ouellet-Courtois C, Roberts A, Skårderud F, Fonagy P.

Trials. 2016 Nov 17;17(1):549.

30.

Measurement error, time lag, unmeasured confounding: Considerations for longitudinal estimation of the effect of a mediator in randomised clinical trials.

Goldsmith KA, Chalder T, White PD, Sharpe M, Pickles A.

Stat Methods Med Res. 2018 Jun;27(6):1615-1633. doi: 10.1177/0962280216666111. Epub 2016 Sep 19.

31.

Cognitive behaviour therapy for chronic fatigue syndrome: Differences in treatment outcome between a tertiary treatment centre in the United Kingdom and the Netherlands.

Worm-Smeitink M, Nikolaus S, Goldsmith K, Wiborg J, Ali S, Knoop H, Chalder T.

J Psychosom Res. 2016 Aug;87:43-9. doi: 10.1016/j.jpsychores.2016.06.006. Epub 2016 Jun 11.

PMID:
27411751
32.

Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.

Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar A.

Cancer Med. 2016 Jul;5(7):1416-24. doi: 10.1002/cam4.713. Epub 2016 Apr 25.

33.

Perceived impact of body feedback from romantic partners on young adults' body image and sexual well-being.

Goldsmith KM, Byers ES.

Body Image. 2016 Jun;17:161-70. doi: 10.1016/j.bodyim.2016.03.008. Epub 2016 Apr 14.

PMID:
27085111
34.

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.

Tanos R, Karmali D, Nalluri S, Goldsmith KC.

BMC Cancer. 2016 Feb 13;16:97. doi: 10.1186/s12885-016-2129-0.

35.

Patient reaction to the PACE trial - Authors' reply.

Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD.

Lancet Psychiatry. 2016 Feb;3(2):e8-9. doi: 10.1016/S2215-0366(16)00018-3. Epub 2016 Jan 19. No abstract available.

PMID:
26795760
36.

Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.

Kumar R, Maynard CL, Eipers P, Goldsmith KT, Ptacek T, Grubbs JA, Dixon P, Howard D, Crossman DK, Crowley MR, Benjamin WH Jr, Lefkowitz EJ, Weaver CT, Rodriguez JM, Morrow CD.

BMC Microbiol. 2016 Jan 13;16:5. doi: 10.1186/s12866-015-0622-2.

37.

Establishing how psychological therapies work: the importance of mediation analysis.

Windgassen S, Goldsmith K, Moss-Morris R, Chalder T.

J Ment Health. 2016;25(2):93-9. doi: 10.3109/09638237.2015.1124400. Epub 2016 Jan 6.

PMID:
26732531
38.

Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.

Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD.

Lancet Psychiatry. 2015 Dec;2(12):1067-74. doi: 10.1016/S2215-0366(15)00317-X. Epub 2015 Oct 28.

PMID:
26521770
39.

Methods and outcome reporting in the PACE trial--Author's reply.

Chalder T, Goldsmith KA, White PD, Sharpe M, Pickles AR.

Lancet Psychiatry. 2015 Apr;2(4):e10-1. doi: 10.1016/S2215-0366(15)00114-5. Epub 2015 Mar 31. No abstract available.

PMID:
26360091
40.

Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial.

Chalder T, Goldsmith KA, White PD, Sharpe M, Pickles AR.

Lancet Psychiatry. 2015 Feb;2(2):141-52. doi: 10.1016/S2215-0366(14)00069-8. Epub 2015 Jan 28.

PMID:
26359750
41.

Information Needs Assessment for Coastal and Marine Management and Policy: Ecosystem Services Under Changing Climatic, Land Use, and Demographic Conditions.

Goldsmith KA, Granek EF, Lubitow A.

Environ Manage. 2015 Dec;56(6):1502-13. doi: 10.1007/s00267-015-0576-z. Epub 2015 Jul 2.

PMID:
26133482
42.

What is Novel About Novel Ecosystems: Managing Change in an Ever-Changing World.

Truitt AM, Granek EF, Duveneck MJ, Goldsmith KA, Jordan MP, Yazzie KC.

Environ Manage. 2015 Jun;55(6):1217-26. doi: 10.1007/s00267-015-0465-5. Epub 2015 Mar 31.

PMID:
25822888
43.

EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.

Nalluri S, Peirce SK, Tanos R, Abdella HA, Karmali D, Hogarty MD, Goldsmith KC.

Cancer Biol Ther. 2015;16(2):276-86. doi: 10.1080/15384047.2014.1002333.

44.

Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome.

Dougall D, Johnson A, Goldsmith K, Sharpe M, Angus B, Chalder T, White P.

J Psychosom Res. 2014 Jul;77(1):20-6. doi: 10.1016/j.jpsychores.2014.04.002. Epub 2014 Apr 22.

45.

Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma.

Laetsch TW, Liu X, Vu A, Sliozberg M, Vido M, Elci OU, Goldsmith KC, Hogarty MD.

Cell Death Dis. 2014 Feb 20;5:e1072. doi: 10.1038/cddis.2014.40.

46.

One-day cognitive-behavioural therapy self-confidence workshops for people with depression: randomised controlled trial.

Horrell L, Goldsmith KA, Tylee AT, Schmidt UH, Murphy CL, Bonin EM, Beecham J, Kelly J, Raikundalia S, Brown JS; CLASSIC trial group.

Br J Psychiatry. 2014 Mar;204(3):222-33. doi: 10.1192/bjp.bp.112.121855. Epub 2013 Dec 19.

PMID:
24357574
47.

A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.

Walwyn R, Potts L, McCrone P, Johnson AL, DeCesare JC, Baber H, Goldsmith K, Sharpe M, Chalder T, White PD.

Trials. 2013 Nov 13;14:386. doi: 10.1186/1745-6215-14-386.

48.

PACE trial authors' reply to letter by Kindlon.

White PD, Chalder T, Sharpe M, Johnson T, Goldsmith K.

BMJ. 2013 Oct 15;347:f5963. doi: 10.1136/bmj.f5963. No abstract available.

PMID:
24129374
49.

Negativity bias and task motivation: testing the effectiveness of positively versus negatively framed incentives.

Goldsmith K, Dhar R.

J Exp Psychol Appl. 2013 Dec;19(4):358-66. doi: 10.1037/a0034415. Epub 2013 Sep 23.

PMID:
24059820
50.

Letter to the editor: response to correspondence concerning 'recovery from chronic fatigue syndrome after treatments in the PACE trial'.

White PD, Goldsmith K, Johnson AL, Chalder T, Sharpe M.

Psychol Med. 2013 Aug;43(8):1791-2. doi: 10.1017/S0033291713001311. No abstract available.

PMID:
23866117

Supplemental Content

Loading ...
Support Center